Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

Not Applicable

Completed

• Conditions: Schizophrenia

• Registration Number: NCT01409590
• Lead Sponsor: Sheba Medical Center

Brief Summary

In this study the investigators will recruit patients with the diagnosis of schizophrenia that are taking atypical neuroleptics and that are willing to participate in an exercise and diet program. The investigators will measure weight and abdomen circumference.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Primary Completion: 2006-09
• Study Completion: 2009-08
• Status Verified: 2011-08
• Study First Submitted: 2011-08-03
• Study First Submitted QC: 2011-08-03
• Last Update Submitted: 2011-08-03
• Study First Posted: 2011-08-04
• Last Update Posted: 2011-08-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Schizophrenia
• Atypical neuroleptics

Exclusion Criteria

• Medical illness preventing exercise

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Weight loss	One year	The weight of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Secondary Outcome Measures

Name	Time	Method
Abdomen circumference	One year	The circumference of the abdomen of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Trial Locations

Locations (1)

Sheba Medical Center; 🇮🇱 Tel Hashomer, Ramat Gan, Israel